Home/ Stocks/ COLL

Collegium Pharmaceutical, Inc. Common Stock

COLL XNAS

$37.80 -1.53 (-3.89%) ▼ 15-min delayed

Open

$39.65

High

$40.50

Low

$37.61

Volume

698.0K

Market Cap

$1.23B

About Collegium Pharmaceutical, Inc. Common Stock

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 423 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$193.52M	$14.50M	$0.45
FY 2025	$780.57M	$62.87M	$1.98
Q3 2025	$209.36M	$31.51M	$1.00
Q2 2025	$188.00M	$11.98M	$0.38

Earnings & Analyst Ratings

Next Earnings: Wed, Aug 5, 2026

Calendar →

Related Market News

No specific coverage for COLL yet. Check out our latest market news or earnings calendar.

Get COLL Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Collegium Pharmaceutical, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.